53 related articles for article (PubMed ID: 26332444)
1. Nucleotide-binding oligomerization domain 2 (NOD2) activation induces apoptosis of human oral squamous cell carcinoma cells.
Yoon HE; Ahn MY; Kwon SM; Kim DJ; Lee J; Yoon JH
J Oral Pathol Med; 2016 Apr; 45(4):262-7. PubMed ID: 26332444
[TBL] [Abstract][Full Text] [Related]
2. Structure-activity relationship in NOD2 agonistic muramyl dipeptides.
Kamboj A; Patil MT; Petrovsky N; Salunke DB
Eur J Med Chem; 2024 May; 271():116439. PubMed ID: 38691886
[TBL] [Abstract][Full Text] [Related]
3. Plumbagin Induces Reactive Oxygen Species and Endoplasmic Reticulum Stress-related Cell Apoptosis in Human Oral Squamous Cell Carcinoma.
Chen PH; Lu HK; Renn TY; Chang TM; Lee CJ; Tsao YT; Chuang PK; Liu JF
Anticancer Res; 2024 Mar; 44(3):1173-1182. PubMed ID: 38423664
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and validation of click-modified NOD1/2 agonists.
Bharadwaj R; Anonick MV; Jaiswal S; Mashayekh S; Brown A; Wodzanowski KA; Okuda K; Silverman N; Grimes CL
Innate Immun; 2023 Nov; 29(8):186-200. PubMed ID: 37828863
[TBL] [Abstract][Full Text] [Related]
5. Role of the nucleotide-binding oligomerization domain-containing protein 1 pathway in the development of periodontitis.
Mao D; Inoue H; Goda S
J Oral Biosci; 2024 Mar; 66(1):105-111. PubMed ID: 38182046
[TBL] [Abstract][Full Text] [Related]
6. Research Progress of Metformin in the Treatment of Oral Squamous Cell Carcinoma.
Liu J; Zhao J; Qiao X
Endocrinology; 2023 Sep; 164(11):. PubMed ID: 37738154
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic Effects of Perilla Phenols in Oral Squamous Cell Carcinoma.
Lee CH; Tsao YH; Weng YP; Wang IC; Chen YP; Hung PF
Int J Mol Sci; 2023 Oct; 24(19):. PubMed ID: 37834377
[TBL] [Abstract][Full Text] [Related]
8. Cytotoxic, anti-proliferative, and apoptotic evaluation of Ramalina sinensis (Ascomycota, Lecanoromycetes), lichenized fungus on oral squamous cell carcinoma cell line; in-vitro study.
Koopaie M; Karimi H; Sohrabi M; Norouzi H
BMC Complement Med Ther; 2023 Aug; 23(1):296. PubMed ID: 37608377
[TBL] [Abstract][Full Text] [Related]
9. Nucleotide-binding oligomerization domain protein-1 is expressed and involved in the inflammatory response in human sebocytes.
Kitajima N; Nakajo T; Katayoshi T; Tsuji-Naito K
Biochem Biophys Rep; 2023 Dec; 36():101561. PubMed ID: 37942338
[TBL] [Abstract][Full Text] [Related]
10. Podophyllotoxin reduces the aggressiveness of human oral squamous cell carcinoma through myeloid cell leukemia‑1.
Yu HJ; Shin JA; Choi SJ; Cho SD
Int J Mol Med; 2023 Nov; 52(5):. PubMed ID: 37711052
[TBL] [Abstract][Full Text] [Related]
11. Luteolin suppresses oral carcinoma 3 (OC3) cell growth and migration via modulating polo-like kinase 1 (PLK1) expression and cellular energy metabolism.
Gao P; Zhang W; Lin Y; Lu R; Lou Z; Lu G; Pan R; Chen Y
J Zhejiang Univ Sci B; 2023 Dec; 24(12):1151-1158. PubMed ID: 38057271
[TBL] [Abstract][Full Text] [Related]
12. A Bacterial Nanomedicine Combines Photodynamic-Immunotherapy and Chemotherapy for Enhanced Treatment of Oral Squamous Cell Carcinoma.
Shi E; Shan T; Wang H; Mao L; Liang Y; Cao M; Wu Q; Li C; Wang Y; Wang Y
Small; 2023 Dec; 19(52):e2304014. PubMed ID: 37653616
[TBL] [Abstract][Full Text] [Related]
13. Identification, characterization and the inflammatory regulating effect of NOD1/2 in sturgeon.
Chen D; Zhu H; Lu L; Chen Y; Zhang X; Huang X; Ouyang P; Geng Y; Li Z
Fish Shellfish Immunol; 2024 Mar; 146():109407. PubMed ID: 38281612
[TBL] [Abstract][Full Text] [Related]
14. Anti-growth and pro-apoptotic effects of dasatinib on human oral cancer cells through multi-targeted mechanisms.
Park NS; Park YK; Yadav AK; Shin YM; Bishop-Bailey D; Choi JS; Park JW; Jang BC
J Cell Mol Med; 2021 Sep; 25(17):8300-8311. PubMed ID: 34318593
[TBL] [Abstract][Full Text] [Related]
15. IL-1α facilitates GSH synthesis to counteract oxidative stress in oral squamous cell carcinoma under glucose-deprivation.
Ji Y; Zhang Z; Zhao X; Li Z; Hu X; Zhang M; Pan X; Wang X; Chen W
Cancer Lett; 2024 May; 589():216833. PubMed ID: 38548217
[TBL] [Abstract][Full Text] [Related]
16. Considerations regarding the tumor-suppressor role of naringenin as a novel agent for the treatment of oral squamous cell carcinoma.
Li CX; Gong ZC; Tan XR
Cancer Immunol Immunother; 2023 Sep; 72(9):3133-3134. PubMed ID: 37149552
[No Abstract] [Full Text] [Related]
17. Chronotherapeutics in the management of oral squamous cell carcinoma - A futuristic novel treatment strategy.
Poornachitra P; Muthukrishnan A; Devaraj E
Indian J Cancer; 2023 Oct; 60(4):595-596. PubMed ID: 38185867
[No Abstract] [Full Text] [Related]
18. Meridianin C inhibits the growth of YD-10B human tongue cancer cells through macropinocytosis and the down-regulation of Dickkopf-related protein-3.
Park NS; Park YK; Ramalingam M; Yadav AK; Cho HR; Hong VS; More KN; Bae JH; Bishop-Bailey D; Kano J; Noguchi M; Jang IS; Lee KB; Lee J; Choi JS; Jang BC
J Cell Mol Med; 2018 Dec; 22(12):5833-5846. PubMed ID: 30246484
[TBL] [Abstract][Full Text] [Related]
19. Discovery of fluorinated 2‑Styryl 4(3H)-quinazolinone as potential therapeutic hit for oral cancer.
Parshuram Satpute D; Shirwadkar U; Kumar Tharalla A; Dattatray Shinde S; Nikhil Vaidya G; Joshi S; Patel Vatsa P; Jain A; Singh AA; Garg R; Mandoli A; Kumar D
Bioorg Med Chem; 2023 Mar; 81():117193. PubMed ID: 36796126
[TBL] [Abstract][Full Text] [Related]
20. Ferroptosis Mediated Novel Drug Design Approach in the Treatment of Oral Squamous Cell Carcinoma.
S D; Ramani P; Doble M; Ramasubramanian A
Asian Pac J Cancer Prev; 2023 Jul; 24(7):2321-2327. PubMed ID: 37505762
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
